clarithromycin has been researched along with Lung Diseases in 84 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (7.14) | 18.2507 |
2000's | 25 (29.76) | 29.6817 |
2010's | 40 (47.62) | 24.3611 |
2020's | 13 (15.48) | 2.80 |
Authors | Studies |
---|---|
Anderson, S; Barker, L; Burger, MT; Carroll, GL; Chu, DT; Desai, MC; Hiebert, C; Huh, K; Kidney, J; Langhorne, M; Lin, X; Plattner, JJ; Rico, AC; Seid, M; Shawar, R; Young, K | 1 |
Enoki, Y; Fukunaga, K; Hasegawa, N; Kizu, J; Matsumoto, K; Namkoong, H; Ozawa, T; Taguchi, K; Takahashi, Y; Takaya, R | 1 |
Hachisu, Y; Hisada, T; Ito, M; Koga, Y; Maeno, T; Murata, K; Sunaga, N | 1 |
Hiramine, S; Kibe, Y; Kimura, S; Matsumoto, Y; Murata, M; Nishida, R; Shimono, N; Shiose, A; Sonoda, H; Takayama, K; Toyoda, K; Yamasaki, S | 1 |
Aoki, A; Inagaki, T; Jinno, H; Nakagawa, T; Ogawa, K; Okamoto, Y; Uchiya, KI; Wajima, T | 1 |
Arai, T; Inoue, Y; Kobayashi, T; Tsuyuguchi, K; Yoshida, S | 1 |
Jhun, BW; Kim, LH; Kim, SY; Lee, JM; Lee, W; Shin, SJ | 1 |
Chong, YP; Han, M; Jo, KW; Kim, OH; Kwon, BS; Kwon, YS; Lee, HY; Shim, TS | 1 |
Adachi, Y; Hayashi, S; Kagawa, T; Kobayashi, T; Kurahara, Y; Suzuki, K; Tsuyuguchi, K; Yoshida, S | 1 |
Chang, CL; Chen, LC; Chien, JY; Hsueh, PR; Yu, CJ | 1 |
Aono, A; Fujiwara, K; Furuuchi, K; Kurashima, A; Mitarai, S; Morimoto, K; Ohta, K; Osawa, T; Shimoda, M; Takaki, A; Uesugi, F | 1 |
Atsumi, J; Hiramatsu, M; Morimoto, K; Shimoda, K; Shiraishi, Y; Togo, T | 1 |
Guo, Y; Wan, B; Wang, H; Wang, W; Wu, X; Yang, J; Yu, F | 1 |
Ando, T; Kage, H; Matsumoto, Y; Nagase, T; Zokumasu, K | 1 |
Adir, Y; Lavon, O; Schneer, S; Shteinberg, M | 1 |
Arar, D; Barisic, I; Goic-Barisic, I; Katalinic-Jankovic, V; Makek, MJ; Novak, A; Peric, I; Popovic, DR; Popovic, V; Rubic, Z; Tonkic, M | 1 |
Dick, T; Mukherjee, D; Teo, JWP; Wu, ML | 1 |
Han, SK; Kim, TS; Lee, JH; Lee, JS; Seong, MW; Yim, JJ; Yoon, SH | 1 |
Hosono, Y; Kagawa, H; Kitada, S; Miki, K; Miki, M; Mori, M; Oshitani, Y; Yano, Y; Yokota, S; Yoshimura, K | 1 |
Dalcolmo, MP; Daley, CL; Eather, G; Gayoso, R; Hasegawa, N; Jhun, BW; Koh, WJ; Kwak, N; Namkoong, H; Park, J; Thomson, R; van Ingen, J; Yim, JJ; Zweijpfenning, SMH | 1 |
Gumbo, T; Pasipanodya, JG | 1 |
Amighi, K; Pilcer, G; Rosière, R; Sebti, T; Traina, K; Vanderbist, F | 1 |
Jeon, K; Jeong, BH; Koh, WJ; Lee, SY; Shin, SJ | 2 |
Amighi, K; De Bueger, V; Pilcer, G; Sebti, T; Traina, K; Traore, H; Vanderbist, F | 1 |
Chen, PR; Tan, SY | 1 |
Cho, SN; Jeon, K; Kim, SY; Koh, WJ; Kwon, OJ; Park, HY; Shin, SJ | 1 |
Brown-Elliott, BA; Griffith, DE; Killingley, J; McNulty, S; Philley, JV; Shepherd, S; Wallace, RJ; Wilson, RW; York, DS | 1 |
Ihi, T; Ishii, H; Kadota, J; Komiya, K; Kudoh, S; Kurashima, A; Matsumoto, N; Mizunoe, S; Nagai, H; Ohta, K; Takahashi, O | 1 |
Patsche, CB; Svensson, E; Wejse, C | 1 |
Field, SK; Jarand, J | 1 |
Daley, CL; Huh, HJ; Jeon, K; Jeong, BH; Ki, CS; Kim, SY; Koh, WJ; Lee, NY; Park, HY; Shin, SJ | 1 |
Asano, F; Masuda, A; Matsumoto, S; Matsuno, Y; Murakami, A; Sobajima, T; Tsuzuku, A | 1 |
Holland, SM; Moura, NS; Olivier, KN; Sampaio, EP; Shallom, SJ; Zelazny, AM | 1 |
Adderson, EE; Apiwattankul, N; Flynn, PM; Hayden, RT | 1 |
Hashiguchi, N; Inoshima, I; Inoshima, N | 1 |
Akaba, T; Akagawa, S; Akashi, S; Hirose, T; Kadota, T; Kawashima, M; Kobayashi, K; Kobayashi, N; Matsui, H; Nagai, H; Ohta, K; Saito, M; Suzuki, J; Tamura, A | 1 |
Jeong, BH; Kim, SY; Koh, WJ; Shin, SJ | 1 |
Betsuyaku, T; Goto, H; Hasegawa, N; Hayashi, Y; Hoshino, Y; Ishii, M; Izumi, K; Kurashima, A; Matsuda, S; Morimoto, K; Morino, E; Nakagawa, T; Namkoong, H; Nishimura, T; Ogawa, K; Sasaki, Y; Shiraishi, Y; Takasaki, J; Yoshiyama, T | 1 |
Andréjak, C; Chabot, F; Godbert, B; Hermann, J; Huet, D; Zordan, JM | 1 |
Choi, YS; Daley, CL; Huh, HJ; Jeon, K; Jeong, BH; Jhun, BW; Ki, CS; Kim, CK; Kim, DH; Kim, H; Kim, HK; Kim, J; Kim, SY; Koh, WJ; Kwon, OJ; Lee, H; Lee, NY; Lee, SH; Park, HY; Park, KU; Shin, SJ | 1 |
Cho, J; Han, SK; Lee, CH; Park, J; Yim, JJ | 1 |
Lesic, AR; Pesut, DP; Stevic, RS; Stjepanovic, MI | 1 |
Kadota, JI; Kurashima, A; Suzuki, K | 1 |
Benden, C; Boehler, A | 1 |
Fukunaga, K; Hasegawa, N; Ishii, K; Ishizaka, A; Miyairi, M; Nishimura, T; Ohtani, S; Takeshita, K; Tasaka, S; Urano, T | 1 |
Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK | 1 |
Jung Kwon, O; Kim, HJ; Kim, JM; Koh, WJ; Shin, SJ; Sohn, H | 1 |
Randhawa, K; Smethurst, P; Soo Hoo, GW | 1 |
Jeon, K; Koh, WJ; Kwon, OJ; Park, HY; Sim, YS; Suh, GY | 1 |
Huang, YC; Kao, CC; Lin, CF; Liu, MF; Liu, PY; Shen, GH; Shi, ZY | 1 |
Chi, SY; Kim, EY; Kim, KS; Kim, YC; Kim, YI; Kwon, YS; Lim, SC; Oh, IJ | 1 |
Kazumi, Y; Kudoh, S; Kurashima, A; Maeda, S; Morimoto, K; Ogata, H; Yoshimori, K; Yoshiyama, T | 1 |
Fujita, M; Harada, E; Ikegame, S; Kajiki, A; Matsumoto, T; Miyazaki, M; Nakanishi, Y; Ouchi, H; Tao, Y; Uchino, J; Watanabe, K | 1 |
Ding, FM; Jiang, YQ; Shen, C; Zhu, SL | 1 |
Schluger, NW | 1 |
Jeon, K; Koh, WJ; Shin, SJ | 1 |
Gochi, M; Kaneko, Y; Kinoshita, A; Kuwano, K; Saitou, Z; Samejima, T; Seki, A; Seki, Y; Takeda, H | 1 |
Brown-Elliott, BA; Couch, L; Girard, WM; Griffith, DE; Mann, L; Wallace, RJ; Wilson, RW; Yakrus, MA; Zhang, Y | 1 |
Abe, T; Eda, R; Kobashi, Y; Kobayashi, K; Kuraoka, T; Matsushima, T; Mori, K; Moritaka, T; Nishimura, K; Ohnishi, T; Okimoto, N; Shigetou, E; Takeyama, H; Ueda, Y; Yano, S | 1 |
Amitani, R; Kimoto, T; Suzuki, K; Tanaka, E; Tsuyuguchi, K | 1 |
Doern, GV; Ernst, EJ; Hoffman, HL; Klepser, ME; Petzold, CR; Sa'adah, LM | 1 |
Shimokata, K | 1 |
Kobashi, Y; Matsushima, T | 1 |
Brown-Elliott, BA; Griffith, DE; Wallace, RJ | 1 |
Avozani, M; Camozzato, C; Jones, MH; Machado, DC; Pinto, LA; Pitrez, PM; Stein, RT | 1 |
De Schepper, J; De Schutter, I; De Wachter, E; Malfroot, A; Vanbesien, J | 1 |
Berthold, F; Ebeling, O; Handrick, W; Schwede, I; Wogawa, B | 1 |
Fujiwara, K | 1 |
Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D | 1 |
Ayaz, C; Celen, MK; Geyik, MF; Hosoglu, S; Ozmen, E | 1 |
Kobashi, Y; Miyashita, N; Niki, Y; Oka, M; Yoshida, K | 1 |
Freudenberger, R; Mahal, M; Mateo-Bibeau, R; Naik, S; Shinnar, M | 1 |
Kuwabara, K; Tsuchiya, T | 1 |
Chauvin, JP; Dautzenberg, B; Diot, P; Piperno, D; Truffot-Pernot, C | 1 |
Frothingham, R | 1 |
Brown, BA; Griffith, DE; Wallace, RJ | 1 |
Alder, JD; Ewing, PJ; Jarvis, K; Mitten, M; Nilius, AM; Oleksijew, A; Paige, L; Tanaka, SK; Tovcimak, A | 1 |
Griffith, DE | 1 |
Brown, BA; Cegielski, P; Griffith, DE; Murphy, DT; Wallace, RJ | 1 |
Alfa, M; Harding, G; Kabani, A; Thibert, L; Turenne, C; Wolfe, J | 1 |
Amthor, M; Burkhardt, U; Ernst, M; Richter, E; Rosahl, W; Rüsch-Gerdes, S; Schreiber, J; Zugehör, M | 1 |
Ho, AD; Kornacker, M; Kraemer, A; Leo, E | 1 |
Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Swanson, R; Vallée, E | 1 |
5 review(s) available for clarithromycin and Lung Diseases
Article | Year |
---|---|
Treatment strategies with alternative treatment options for patients with Mycobacterium avium complex pulmonary disease.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2022 |
[LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Lung Diseases; Macrolides | 2016 |
Topics: Aged; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Databases, Factual; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.
Topics: Adolescent; Amikacin; Anti-Infective Agents; Catheter-Related Infections; Child; Child, Preschool; Clarithromycin; Debridement; Female; Humans; Immunocompromised Host; Infant; Lung Diseases; Male; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Neoplasms; Retrospective Studies | 2015 |
Mycobacteria as pathogens of respiratory infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; BCG Vaccine; Clarithromycin; Humans; Lung Diseases; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Mycobacterium tuberculosis; Protease Inhibitors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
8 trial(s) available for clarithromycin and Lung Diseases
Article | Year |
---|---|
Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Toxic Optic Neuropathy | 2021 |
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Genotype; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Recurrence; Retrospective Studies; Sputum; Treatment Outcome | 2017 |
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Treatment Outcome | 2012 |
The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Prospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2003 |
Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii | 2003 |
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Radiography; Treatment Outcome | 2006 |
Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France.
Topics: Aged; Clarithromycin; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Prospective Studies; Treatment Outcome | 1995 |
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; HIV Seronegativity; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Sputum; Treatment Outcome | 2000 |
71 other study(ies) available for clarithromycin and Lung Diseases
Article | Year |
---|---|
Synthesis and antibacterial activity of novel C12 vinyl ketolides.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Enterococcus faecalis; Haemophilus Infections; Haemophilus influenzae; Half-Life; Ketolides; Lung Diseases; Male; Microbial Sensitivity Tests; Pneumococcal Infections; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Vinyl Compounds | 2006 |
Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system.
Topics: Clarithromycin; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Japan; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2022 |
A case of mediastinal abscess and infected aortic aneurysm caused by dissemination of Mycobacterium abscessus subsp. massiliense pulmonary disease.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Aortic Aneurysm; Clarithromycin; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2023 |
A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Leprostatic Agents; Lung Diseases; Macrolides; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis | 2023 |
Cases of severe Mycobacterium avium lung disease occurred in a married couple caused by identical strain.
Topics: Aged; Clarithromycin; Female; Humans; Lung Diseases; Male; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2023 |
Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Humans; Lung Diseases; Macrolides; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones | 2023 |
Discontinuation rates attributed to adverse events and treatment outcomes between clarithromycin and azithromycin in Mycobacterium avium complex lung disease: A propensity score analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Humans; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Propensity Score; Retrospective Studies; Treatment Outcome | 2020 |
Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prognosis; Respiratory Tract Infections; Retrospective Studies; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Taiwan; Young Adult | 2020 |
Mycobacterium europaeum lung disease in an immunocompetent patient without underlying lung disease.
Topics: Aged; Clarithromycin; Ethambutol; Female; Humans; Lung Diseases; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2021 |
A Novel Approach to Extensive Clarithromycin-Resistant Mycobacterium avium Complex Pulmonary Disease.
Topics: Anti-Bacterial Agents; Clarithromycin; Female; Humans; Lung Diseases; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 2022 |
Difference in drug susceptibility distribution and clinical characteristics between
Topics: Adult; Aged; Anti-Bacterial Agents; China; Ciprofloxacin; Clarithromycin; Cough; Doxycycline; Drug Resistance, Bacterial; Female; Humans; Lung; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography; Sputum | 2021 |
Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Croatia; Female; Humans; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Streptomycin; Treatment Outcome | 2018 |
Vancomycin and Clarithromycin Show Synergy against
Topics: Antibiotics, Antitubercular; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Humans; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Treatment Outcome; Vancomycin | 2017 |
Implication of species change of Nontuberculous Mycobacteria during or after treatment.
Topics: Aged; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Seoul; Severity of Illness Index; Tomography, X-Ray Computed | 2017 |
The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Sputum; Time Factors | 2018 |
Drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Monitoring; Female; Humans; Lung Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2013 |
New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Desiccation; Drug Delivery Systems; Humans; Lung; Lung Diseases; Nanoparticles; Powders; Respiratory Tract Infections; Solubility; Tobramycin | 2013 |
Reply: drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Monitoring; Female; Humans; Lung Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2013 |
Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Crystallization; Cystic Fibrosis; Drug Combinations; Drug Compounding; Drug Synergism; Dry Powder Inhalers; Lung; Lung Diseases; Microscopy, Electron, Scanning; Particle Size; Powders; Tissue Distribution; Tobramycin; X-Ray Diffraction | 2013 |
[The treatment outcomes of 21 cases of rapidly growing mycobacteria related pulmonary disease].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome; Young Adult | 2013 |
Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin; Th1 Cells; Th17 Cells; Th2 Cells | 2014 |
Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Follow-Up Studies; Genotype; Humans; Lung Diseases; Macrolides; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Sputum; Treatment Outcome | 2014 |
Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Propensity Score; Retrospective Studies; Treatment Outcome | 2014 |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung; Lung Diseases; Mycobacterium; Mycobacterium Infections; Pyrazinamide; Radiography | 2014 |
Embrace simplicity when treating lady windermere.
Topics: Azithromycin; Bronchiectasis; Clarithromycin; Female; Humans; Lung Diseases; Macrolides; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2014 |
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
Topics: Aged; Anti-Bacterial Agents; Bronchiectasis; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum | 2015 |
A Case of Pulmonary Actinomycosis Associated With Aspiration of Cedar Leaves.
Topics: Actinomyces; Actinomycosis; Anti-Bacterial Agents; Biopsy; Bronchoscopy; Cedrus; Clarithromycin; Female; Foreign Bodies; Humans; Levofloxacin; Lung Abscess; Lung Diseases; Middle Aged; Rare Diseases; Tomography, X-Ray Computed | 2015 |
New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Lung Diseases; Methyltransferases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Polymorphism, Single Nucleotide; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Soft Tissue Infections | 2015 |
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION SUCCESSFULLY TREATED WITH SHORT-TERM CAM, AMK, AND IPM/cs FOLLOWED BY LONG-TERM ORAL CAM AND LVFX].
Topics: Administration, Oral; Aged; Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Female; Humans; Imipenem; Levofloxacin; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2015 |
Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; C-Reactive Protein; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Risk Factors; Serum Albumin; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Female; Humans; Lung Diseases; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Point Mutation | 2016 |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Female; Humans; Inappropriate Prescribing; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Diseases; Macrolides; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculosis, Multidrug-Resistant | 2016 |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment].
Topics: Clarithromycin; Diagnosis, Differential; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Rifampin; Tuberculosis, Pulmonary | 2017 |
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Progression; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Risk Factors; Sputum; Treatment Outcome | 2017 |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report.
Topics: Aged; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Humans; Lung Diseases; Male; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Respiratory Insufficiency; Rifampin; Risk Factors; Spinal Diseases; Sputum | 2016 |
The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Marketing; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Sputum; Treatment Outcome | 2017 |
Long-term clarithromycin therapy in the management of lung transplant recipients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Bronchiolitis Obliterans; Child; Clarithromycin; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Lung Diseases; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Young Adult | 2009 |
Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchiectasis; Clarithromycin; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Thrombocytopenia; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
High virulent clinical isolates of Mycobacterium abscessus from patients with the upper lobe fibrocavitary form of pulmonary disease.
Topics: Adult; Aged; Animals; Anti-Bacterial Agents; Cell Survival; Clarithromycin; Cytokines; Drug Resistance, Bacterial; Female; Humans; Lung; Lung Diseases; Macrophages; Male; Mice; Mice, Inbred C57BL; Middle Aged; Mycobacterium; Mycobacterium Infections; Specific Pathogen-Free Organisms; Tomography, X-Ray Computed; Virulence | 2009 |
Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.
Topics: Antitubercular Agents; Clarithromycin; Delayed Diagnosis; Disease Progression; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2010 |
Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2010 |
Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Outcome | 2010 |
Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Treatment Outcome | 2011 |
Mycobacterium heckeshornense lung infection that was diagnosed as Mycobacterium xenopi disease by DNA-DNA hybridization (DDH).
Topics: Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; DNA Probes; DNA, Bacterial; Humans; Japan; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Species Specificity; Treatment Outcome | 2011 |
Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage; Clarithromycin; Disease Models, Animal; Female; Immunohistochemistry; Interleukin-17; Interleukin-4; Lung Diseases; Mice; Mice, Inbred BALB C; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; Respiratory Tract Infections; Stem Cells; T-Lymphocytes, Regulatory | 2012 |
Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Logistic Models; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Republic of Korea; Retrospective Studies; Rifabutin; Rifampin | 2012 |
Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Monitoring; Female; Humans; Lung Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2012 |
Successful treatment of Mycobacterium massiliense lung disease with oral antibiotics only.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Aza Compounds; Bronchiectasis; Clarithromycin; Female; Fluoroquinolones; Humans; Lung Diseases; Moxifloxacin; Mycobacterium; Quinolines | 2013 |
[Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
Topics: Adult; Clarithromycin; Cysts; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Tuberculosis, Pulmonary | 2012 |
Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polymerase Chain Reaction; Prospective Studies; Sputum | 2002 |
[Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Retrospective Studies; Treatment Outcome | 2002 |
Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection.
Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Humans; Lactams; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous | 2002 |
Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Half-Life; Humans; Lung Diseases; Mice; Microbial Sensitivity Tests; Serotyping; Streptococcal Infections; Streptococcus pneumoniae | 2003 |
Treatment of pulmonary disease caused by Mycobacterium avium complex.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2003 |
Effect of clarithromycin on the cell profile of bronchoalveolar lavage fluid in mice with neutrophil-predominant lung disease.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cell Count; Clarithromycin; Disease Models, Animal; Lung Diseases; Male; Mice; Neutrophils; Pseudomonas aeruginosa | 2004 |
Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchodilator Agents; Budesonide; Clarithromycin; Cushing Syndrome; Cystic Fibrosis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Fatal Outcome; Female; Humans; Iatrogenic Disease; Infant, Newborn; Itraconazole; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous | 2003 |
[Pulmonary infection due to Mycobacterium malmoense].
Topics: Azithromycin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin | 2005 |
[A case of Mycobacterium intracellulare lung disease that was detected by health examination and was successfully cured by chemotherapy--including discussions on the diagnostic criteria of the disease].
Topics: Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Magnetic Resonance Imaging; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tomography, X-Ray Computed | 2005 |
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin | 2006 |
Development of pneumatoceles after viral infection.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Cefotaxime; Clarithromycin; Cysts; Humans; Lung Diseases; Male; Radiography; Staphylococcus aureus; Time Factors | 2006 |
Successful treatment of Nocardia nova bacteremia and multilobar pneumonia with clarithromycin in a heart transplant patient.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Heart Transplantation; Humans; Lung Diseases; Male; Nocardia Infections; Pneumonia; Postoperative Complications | 2007 |
[Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
Topics: Aged; Bronchiectasis; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2007 |
Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Humans; Lung Diseases; Mycobacterium avium-intracellulare Infection; Protein Synthesis Inhibitors | 1996 |
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease.
Topics: Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV; Humans; Leukocyte Count; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Platelet Count; Rifabutin | 1996 |
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Lung Diseases; Rats; Rats, Sprague-Dawley | 1998 |
Mycobacterium branderi from both a hand infection and a case of pulmonary disease.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Clarithromycin; DNA, Ribosomal; Drug Therapy, Combination; Female; Hand; Humans; Lung Diseases; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycolic Acids; RNA, Ribosomal, 16S; Skin Diseases, Bacterial; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
[Non-tubercular mycobacterial infection of the lungs due to Mycobacterium smegmatis].
Topics: Cardiopulmonary Resuscitation; CD4-Positive T-Lymphocytes; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Ofloxacin; Radiography; Rifabutin | 2001 |
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Diseases; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Prednisolone; Prednisone; Rituximab; Sarcoidosis; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 2002 |
Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Lung Diseases; Mice; Mice, Inbred C57BL | 1991 |